| Literature DB >> 23029576 |
Estefanía Custodio1, Endalamaw Gadisa, Luis Sordo, Israel Cruz, Javier Moreno, Javier Nieto, Carmen Chicharro, Abraham Aseffa, Zelalem Abraham, Tsegaye Hailu, Carmen Cañavate.
Abstract
BACKGROUND: In northern Ethiopia the prevalence of visceral leishmaniasis is steadily rising posing an increasing public health concern. In order to develop effective control strategies on the transmission of the disease it is important to generate knowledge on the epidemiological determinants of the infection. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 23029576 PMCID: PMC3459849 DOI: 10.1371/journal.pntd.0001813
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Location of the study area.
Figure 2Location of the sub-districts on which the study was performed (grey background).
Figures were adapted from Alvar et al. Am. J. Trop. Med. Hyg., 77(2), 2007, pp. 275–282.
Asymptomatic infection, seropositivity and LST positivity prevalence by gott.
| Asymptomatic infection | Seropositive | LST positive | ||||||||
| Name of cluster/Gott | Kebele | Woreda | N | n | % | n | % | N | n | % |
| Fogerie Mender | Agita | Libo Kemkem | 29 | 0 | 0 | 0 | 0 | 29 | 0 | 0 |
| Fuat Fuat | Agita | Libo Kemkem | 29 | 2 | 6.9 | 2 | 6.9 | 26 | 0 | 0 |
| Gilgel Terara | Agita | Libo Kemkem | 32 | 0 | 0 | 0 | 0 | 29 | 0 | 0 |
| Melagud | Agita | Libo Kemkem | 28 | 0 | 0 | 0 | 0 | 28 | 0 | 0 |
| Medroge | Bura | Libo Kemkem | 42 | 9 | 21.4 | 8 | 19 | 42 | 6 | 14.3 |
| Mehal-Egziabherab | Bura | Libo Kemkem | 28 | 9 | 32.14 | 1 | 3.6 | 28 | 8 | 28.6 |
| Menta-Warka | Bura | Libo Kemkem | 26 | 8 | 30.7 | 6 | 23.1 | 26 | 2 | 7.7 |
| Quara | Bura | Libo Kemkem | 32 | 5 | 15.6 | 1 | 3.1 | 31 | 4 | 12.9 |
| Gultoch | D. Sifatra | Fogera | 31 | 3 | 9.7 | 2 | 6.4 | 31 | 2 | 6.4 |
| Lahada | D. Sifatra | Fogera | 33 | 2 | 6.1 | 1 | 3 | 32 | 1 | 3.1 |
| Ras Diba | D. Sifatra | Fogera | 33 | 0 | 0 | 0 | 0 | 32 | 0 | 0 |
| Sifatra | D. Sifatra | Fogera | 28 | 4 | 14.3 | 3 | 10.7 | 25 | 1 | 4 |
| Amaga | Rib Gebriel | Fogera | 30 | 3 | 10 | 3 | 10 | 30 | 0 | 0 |
| Denboch | Rib Gebriel | Fogera | 35 | 2 | 5.7 | 1 | 2.9 | 35 | 1 | 2.9 |
| Gichoch | Rib Gebriel | Fogera | 35 | 2 | 5.7 | 2 | 5.7 | 32 | 2 | 6.2 |
| Gombel | Rib Gebriel | Fogera | 30 | 4 | 13.3 | 2 | 6.7 | 30 | 3 | 10 |
| Ansha | Yifag Akababi | Libo Kemkem | 31 | 2 | 6.4 | 2 | 6.4 | 31 | 0 | 0 |
| Bata | Yifag Akababi | Libo Kemkem | 33 | 1 | 3 | 1 | 3 | 32 | 0 | 0 |
|
| 565 | 56 | 9.9 | 35 | 6.2 | 549 | 30 | 5.5 | ||
As defined in M&M section.
Total number of children with LST performed was 549, % calculated according to that number.
Individual variables associated with asymptomatic infection*. Unadjusted analysis†.
| Asymptomatic infection | Seropositivity | LST positivity | |||||
| Factor | N (%) | Positive n (%) | Odds ratio (95% CI) | Positive n (%) | Odds ratio (95% CI) | Positive n (%) | Odds ratio (95% CI) |
|
| |||||||
| Years | 565 (100) | 56 (9.9) | 1.21 (1.07, 1.36) | 35 (6.2) | 1.15 (1.01, 1.31) | 30 (5.5) | 1.24 (1.07, 1.44) |
|
| 0.002 | 0.03 | 0.004 | ||||
|
| |||||||
| Girl | 276 (48.9) | 16 (5.8) | Reference | 9 (3.26) | Reference | 9 (3.4) | Reference |
| Boy | 289(51.1) | 40 (13.8) | 3.36 (1.55, 7.28) | 26 (9.0) | 3.86 (1.46, 10.24) | 21 (7.5) | 2.66 (1.06, 6.67) |
|
| 0.002 | 0.007 | 0.04 | ||||
|
| |||||||
| Z scores | 562 (99.5) | 56 (9.9) | 0.68 (0.48, 0.98) | 35 (6.2) | 0.70 (0.46, 1.07) | 30 (5.5) | 0.75 (0.49, 1.14) |
|
| 0.04 | 0.1 | 0.18 | ||||
|
| |||||||
| No | 343 (60.8) | 20 (5.8) | Reference | 16 (4.6) | Reference | 7 (2.1) | Reference |
| Yes | 221 (39.2) | 36 (16.3) | 3.46 (1.65, 7.22) | 19 (8.6) | 1.69 (0.74, 3.88) | 23 (10.7) | 6.50 (2.25, 18.73) |
|
| 0.001 | 0.21 | 0.001 | ||||
|
| |||||||
| No | 227 (41.4) | 11 (4.7) | Reference | 9 (3.8) | Reference | 3 (1.3) | Reference |
| Yes | 322 (58.7) | 45 (13.6) | 4.30 (1.80, 10.27) | 26 (7.9) | 2.48 (0.96, 6.40) | 27 (8.4) | 8.25 (2.20, 31.0) |
|
| 0.001 | 0.06 | 0.002 | ||||
|
| |||||||
| No | 317 (59.8) | 38 (11.3) | Reference | 20 (5.9) | Reference | 23 (7.0) | Reference |
| Yes | 213 (40.2) | 18 (7.9) | 0.63 (0.30, 1.33) | 15 (6.6) | 1.12 (0.48, 2.60) | 7 (3.2) | 0.36 (0.13, 1.00) |
|
| 0.23 | 0.79 | 0.05 | ||||
|
| 565 | 56 (9.9) | 35 (6.2) | 30 (5.5) | |||
As defined in the Material and Methods section.
LST = Leishmanin Skin Test.
Odds ratios obtained by univariate random effects logistic regression.
Total number of children with LST performed was 549, % calculated according to that number.
Household characteristics associated with asymptomatic infection*. Unadjusted analysis†.
| Asymptomatic infection | Seropositivity | LST positivity | |||||
| Factor | N (%) | Positive n (%) | Odds ratio (95% CI) | Positive n (%) | Odds ratio (95% CI) | Positive n (%) | Odds ratio (95% CI) |
|
| |||||||
| Persons | 604 (99.8) | 56 (9.9) | 1.28 (1.00, 1.62) | 35 (6.2) | 1.17 (0.90, 1.54) | 30 (5.5) | 1.31 (0.98, 1.75) |
|
| 0.04 | 0.24 | 0.07 | ||||
|
| |||||||
| No | 415 (73.6) | 33 (8.0) | Reference | 18 (4.3) | Reference | 21 (5.2) | Reference |
| Yes | 149 (26.4) | 23 (15.4) | 2.99 (1.28, 7.00) | 17 (11.4) | 4.13 (1.53, 11.17) | 9 (6.2) | 1.66 (0.66, 4.14) |
|
| 0.01 | 0.005 | 0.48 | ||||
|
| |||||||
| No | 502 (88.8) | 43 (8.6) | Reference | 27 (5.4) | Reference | 23 (4.7) | Reference |
| Yes | 63 (11.2) | 13 (20.6) | 3.33 (1.19, 9.32) | 8 (12.7) | 2.92 (0.67, 3.72) | 7 (11.3) | 2.64 (0.83, 8.33) |
|
| 0.02 | 0.07 | 0.09 | ||||
|
| 565 | 56 (9.9) | 35 (6.2) | 30 (5.5) | |||
As defined in the Material and Methods section.
LST = Leishmanin Skin Test.
Odds ratios obtained by univariate random effects logistic regression.
Total number of children with LST performed was 549, % calculated according to that number.
Factors associated with Leishmania asymptomatic infection* in children. Adjusted analysis†.
| Asymptomatic infection | Seropositivity | LST positivity | |
| Factor | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) |
|
| |||
| Years | 1.15 (1.03, 1.29) | 1.14 (1.00, 1.30) | 1.19 (1.02, 1.40) |
|
| 0.02 | 0.07 | 0.03 |
|
| |||
| Girl | Reference | Reference | Reference |
| Boy | 2.56 (1.19, 5.48) | 3.55 (1.31, 9.63) | 1.88 (0.70, 4.94) |
|
| 0.02 | 0.01 | 0.2 |
|
| |||
| No | Reference | ″ | Reference |
| Yes | 2.21 (1.03, 4.71) | 5.51(1.77, 17.20) | |
|
| 0.04 | 0.003 | |
|
| |||
| No | Reference | Reference | |
| Yes | 2.92 (1.25, 6.81) | 4.67 (1.59, 13.75) | ″ |
|
| 0.01 | 0.005 | |
|
| |||
| Corrugated iron | Reference | ||
| Straw | 2.71 (1.21, 6.07) | ″ | ″ |
|
| 0.02 | ||
|
| |||
| No | Reference | ″ | ″ |
| Yes | 4.16 (1.41, 12.31) | ||
|
| 0.01 |
As defined in the Material and Methods section.
Odds Ratios obtained by multivariate random effects logistic regression.
LST = Leishmanin Skin Test.
″Variable not included in the final model for the outcome of interest.